Clinical Trials Logo

Clinical Trial Summary

To evaluate the pharmacokinetic (PK) profiles of ceftaroline and avibactam in adults with augmented renal clearance (ARC).


Clinical Trial Description

To evaluate the single-dose pharmacokinetic (PK) profiles of ceftaroline and avibactam following intravenous (IV) administration of ceftaroline fosamil/avibactam ("CXL") in adults with augmented renal clearance (ARC). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01624246
Study type Interventional
Source Forest Laboratories
Contact
Status Completed
Phase Phase 1
Start date May 2012
Completion date March 2013

See also
  Status Clinical Trial Phase
Terminated NCT02755155 - Optimization of Therapeutic Human Serum Albumin Infusion in Selected Critically Ill Patients Phase 4
Completed NCT01921049 - Systemic Inflammatory Response Syndrome (SIRS) in Patients Undergoing Major Procedures in Oral and Maxillofacial Surgery N/A
Recruiting NCT03493880 - The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments
Completed NCT02728401 - Genotypes and Phenotypes in Pediatric SIRS and Sepsis
Recruiting NCT01724463 - Electronic Application of a Severe Sepsis Screening Tool and Management Bundle N/A
Completed NCT01392508 - IMproved PREdiction of Severe Sepsis in the Emergency Department N/A
Recruiting NCT02871895 - Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
Recruiting NCT02887274 - Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
Terminated NCT01906229 - Lung and Systemic Inflammation in the Critically Ill Patient
Completed NCT03288610 - Prediction of Inflammatory Response and Hypotensive Syndrome After Cardiac Surgery by Preoperative Copeptin Level N/A
Completed NCT01469676 - Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function N/A
Completed NCT02127502 - VENUS: Septic Gene Expression Using SeptiCyte